Patient study code | Pre-study dopamine agonist | Trial arm | First IMP | Daily dose (mg) | Number of days on IMP | Second IMP | Daily dose (mg) | Number of days on IMP |
---|---|---|---|---|---|---|---|---|
PD1 | RPR | 1 | PPX | 2.1 | 3 | RPRa, b | 8 | 134 |
PD2 | RPR | 1 | PPX | 2.62 | 58 | RPR | 10 | 48 |
PD3 | RPR | 2 | RPR | 6 | 51 | PPX | 1.57 | 58 |
PD4 | RPR | 2 | RPR | 4 | 40 | PPX | 1.05 | 55 |
PD5 | Consented but then withdrew before taking first IMP | |||||||
PD6 | PPX | 1 | PPX | 2.1 | 64 | RPR | 8 | 52 |
PD7 | PPX | 2 | RPR | 10 | 13 | PPXa, b | 2.62 | 97 |
PD8 | RPR | 2 | RPR | 12 | 54 | PPX | 3.15 | 62 |
PD9 | PPX | 1 | PPX | 1.57 | 62 | RPR | 6 | 56 |
PD10 | RPR | 1 | PPX | 2.1 | 53 | RPR | 8 | 68 |
PD11 | PPX | 1 | PPX | 1.05 | 48 | RPRb | 4 | 30 |
PD12 | PPX | 2 | RPR | 10 | 52 | PPX | 2.62 | 56 |
PD13 | Consented but then withdrew before taking first IMP | |||||||
PD14 | PPX | 1 | PPX | 0.52 | 52 | RPR | 2 | 37 |
PD15 | Consented but then withdrew before taking first IMP | |||||||
PD16 | PPX | 1 | PPX | 1.57 | 63 | RPR | 6 | 55 |
PD17 | PPX | 2 | RPR | 6 | 60 | PPX | 1.57 | 37 |
PD18 | PPX | 2 | RPR | 6 | 3 | Withdrew from IMP and study | ||
PD19 | RPR | 1 | PPX | 2.1 | 55 | RPR | 8 | 84 |
PD20 | PPX | 2 | RPR | 8 | 66 | PPX | 2.1 | 41 |
PD21 | PPX | 1 | PPX | 3.15 | 100 | RPRb | 12 | 7 |
PD22 | RPR | 2 | RPR | 6 | 55 | PPX | 1.57 | 48 |
PD23 | PPX | 2 | RPR | 8 | 5 | Withdrew from IMP and study | ||
PD24 | RPR | 2 | RPR | 6 | 58 | PPX | 1.57 | 37 |
PD25 | RPR | 2 | RPR | 2 | 68 | PPX | 0.52 | 62 |